Literature DB >> 15728495

Localization of Src homology 2 domain-containing phosphatase 1 (SHP-1) to lipid rafts in T lymphocytes: functional implications and a role for the SHP-1 carboxyl terminus.

Vicki C J Fawcett1, Ulrike Lorenz.   

Abstract

The protein tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) has previously been shown to be a negative regulator of signaling mediated via the TCR. A growing body of evidence indicates that the regulated localization of proteins within certain membrane subdomains, referred to as lipid rafts, is important for the successful transduction of signaling events downstream of the TCR. However, considerably less is known about the localization of negative regulators during these lipid raft-dependent signaling events. In this study we have investigated the subcellular localization of SHP-1 and its role in regulation of TCR-mediated signaling. Our studies demonstrate that in a murine T cell hybridoma as well as in primary murine thymocytes, a fraction of SHP-1 localizes to the lipid rafts, both basally and after TCR stimulation. Interestingly, although SHP-1 localized in the nonraft fractions is tyrosine phosphorylated, the SHP-1 isolated from the lipid rafts lacks the TCR-induced tyrosine phosphorylation, suggesting physical and/or functional differences between these two subpopulations. We identify a requirement for the C-terminal residues of SHP-1 in optimal localization to the lipid rafts. Although expression of SHP-1 that localizes to lipid rafts potently inhibits TCR-mediated early signaling events and IL-2 production, the expression of lipid raft-excluded SHP-1 mutants fails to elicit any of the inhibitory effects. Taken together these studies reveal a key role for lipid raft localization of SHP-1 in mediating the inhibitory effects on T cell signaling events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728495     DOI: 10.4049/jimmunol.174.5.2849

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Enhanced T-cell signaling in cells bearing linker for activation of T-cell (LAT) molecules resistant to ubiquitylation.

Authors:  Lakshmi Balagopalan; Benjamin A Ashwell; Kelsie M Bernot; Itoro O Akpan; Naeha Quasba; Valarie A Barr; Lawrence E Samelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism.

Authors:  Qingyu Yang; Qi Zhang; Xuewu Zhang; Lei You; Wenbiao Wang; Weiyong Liu; Yang Han; Chunqiang Ma; Wei Xu; Junbo Chen; Hua Yang; Pin Wan; Yao Zhou; Yingle Liu; Kailang Wu; Ziwen Yang; Jianguo Wu
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

3.  Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway.

Authors:  Yash Mittal; Yelena Pavlova; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

4.  SHP-1 in T cells limits the production of CD8 effector cells without impacting the formation of long-lived central memory cells.

Authors:  Carla C Fowler; Lily I Pao; Joseph N Blattman; Philip D Greenberg
Journal:  J Immunol       Date:  2010-08-09       Impact factor: 5.422

5.  Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity.

Authors:  Yin Liu; Michael J Kruhlak; Jian-Jiang Hao; Stephen Shaw
Journal:  J Leukoc Biol       Date:  2007-06-15       Impact factor: 4.962

Review 6.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 7.  T cell receptor gene therapy for cancer.

Authors:  Thomas M Schmitt; Gunnar B Ragnarsson; Philip D Greenberg
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

8.  A THEMIS:SHP1 complex promotes T-cell survival.

Authors:  Wolfgang Paster; Annika M Bruger; Kristin Katsch; Claude Grégoire; Romain Roncagalli; Guo Fu; Nicholas R J Gascoigne; Konstantina Nika; Andre Cohnen; Stephan M Feller; Philip C Simister; Kelly C Molder; Shaun-Paul Cordoba; Omer Dushek; Bernard Malissen; Oreste Acuto
Journal:  EMBO J       Date:  2014-12-22       Impact factor: 11.598

9.  Downregulation of inhibitory SRC homology 2 domain-containing phosphatase-1 (SHP-1) leads to recovery of T cell responses in elderly.

Authors:  Aurélie Le Page; Carl Fortin; Hugo Garneau; Nancy Allard; Krassimira Tsvetkova; Crystal Tze Ying Tan; Anis Larbi; Gilles Dupuis; Tamas Fülöp
Journal:  Cell Commun Signal       Date:  2014-01-09       Impact factor: 5.712

10.  A model of an integrated immune system pathway in Homo sapiens and its interaction with superantigen producing expression regulatory pathway in Staphylococcus aureus: comparing behavior of pathogen perturbed and unperturbed pathway.

Authors:  Namrata Tomar; Rajat K De
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.